跳蚤和蜱蟲控制藥物市場、機會、成長動力、產業趨勢分析和預測，2024-2032 年

Flea and Tick Control Medication Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月08日 | 出版商:

Global Market Insights Inc. | 英文 282 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球跳蚤和蜱蟲控制藥物市場估值為 67 億美元，預計 2024 年至 2032 年複合年成長率為 7.1%。對預防性保健措施的認知。美國寵物產品協會 (APPA) 的一份報告強調，67% 的美國家庭（即 8,500 萬個家庭）擁有寵物，這是全球觀察到的趨勢。寵物數量的不斷成長和寵物醫療保健支出的增加推動了對跳蚤和蜱蟲藥物的需求。產品配方的創新，例如新的活性成分和組合產品，也提高了治療功效和安全性，從而帶動了市場成長。

整個跳蚤和蜱蟲控制藥物行業根據產品類型、藥物類型、動物類型、購買管道和地區進行分類。

根據產品類型，跳蚤和蜱蟲控制藥物市場分為咀嚼片、噴霧劑和其他產品類型。咀嚼片細分市場在 2023 年以 32 億美元的銷售額佔據主導地位。它們消除了與局部解決方案相關的混亂，並最大限度地減少了兒童和其他寵物的暴露風險。這些藥物提供全身作用，確保對寵物體內的跳蚤和蜱蟲提供強力的保護。咀嚼片所佔據的巨大市場佔有率凸顯了其日益流行和方便用戶使用的性質。

根據藥物類型，跳蚤和蜱蟲控制藥物市場分為處方藥和非處方藥。 2023 年，OTC 細分市場佔據最高市場佔有率，達到 62.6%。它們可以在寵物商店、藥局和線上平台上購買，讓寵物主人無需獸醫處方即可應對感染。非處方藥解決方案通常更實惠，並且有針對不同寵物和需求的各種選項。人們對寵物健康意識的不斷增強和直接購買的便利性鞏固了非處方藥領域的領先地位。

2023 年，北美跳蚤和蜱蟲控制藥物市場價值為 24 億美元。對研發的大量投資催生了各種創新且有效的產品。主要製藥公司的存在和完善的分銷網路進一步增強了該地區的市場地位。對寵物健康和保健的關注，以及對產品安全和功效的嚴格監管，鞏固了北美的領先地位。

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 10 章：公司簡介

Bayer AG
Boehringer Ingelheim International GmbH
Central Garden and Pet Company
Central Life Sciences
Ceva Sante Animale
Ecto Development LLC
Elanco Animal Health Incorporated
Hartz Mountain Corporation
Merck and Co., Inc.
Penn Veterinary Supply, Inc.
Promika LLC
PetIQ, LLC
Virbac S.A.
Zoetis Inc.

簡介目錄

Product Code: 10734

The Global Flea and Tick Control Medication Market was valued at USD 6.7 billion and is projected to witness a CAGR of 7.1% from 2024 to 2032. The market's expansion is propelled by the growing occurrence of flea and tick-borne diseases in pets, a rise in pet ownership, and greater awareness of preventive healthcare measures. A report from the American Pet Products Association (APPA) highlights that 67% of U.S. households, or 85 million families, own pets, a trend observed worldwide. This growing pet population and increased expenditure on pet healthcare propel the demand for flea and tick medications. Innovations in product formulations, such as new active ingredients and combination products, have also improved treatment efficacy and safety, leading to market growth.

The overall flea and tick control medication industry is classified based on the product type, medication type, animal type, purchase channel and region.

Based on product type, the flea and tick control medication market is categorized into chewables, sprays, and other product types. The chewables segment dominated the market with USD 3.2 billion in 2023. Chewable medications are favored for their convenience, palatability, and effectiveness. They eliminate the mess associated with topical solutions and minimize exposure risks to children and other pets. These medications provide systemic action, ensuring robust protection against fleas and ticks from within the pet's body. The substantial market share held by chewables underscores their rising popularity and user-friendly nature.

Based on medication type, the flea and tick control medication market is segmented into prescription and OTC. The OTC segment held the highest market share of 62.6% in 2023. OTC products dominate due to their accessibility and convenience. They are available at pet stores, pharmacies, and online platforms, allowing pet owners to tackle infestations without a veterinary prescription. OTC solutions are often more affordable and come in various options tailored to different pets and needs. Growing awareness of pet health and the ease of direct purchases solidify the OTC segment's leading position.

North America's flea and tick control medication market was valued at USD 2.4 billion in 2023. North America holds a dominant position due to high pet ownership rates, awareness of parasite-related health concerns, and a robust veterinary healthcare infrastructure. Significant investments in research and development have resulted in a diverse range of innovative and effective products. The presence of major pharmaceutical companies and a well-established distribution network further strengthens the region's market stance. Focus on pet health and wellness, alongside stringent regulations for product safety and efficacy, solidifies North America's leading position.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising awareness of pet health
  - 3.2.1.2 Increasing pet ownership
  - 3.2.1.3 Growing importance of preventive care
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost of medication
  - 3.2.2.2 Adverse effects
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Chewables
5.3 Sprays
5.4 Other product types

Chapter 6 Market Estimates and Forecast, By Medication Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Prescription
6.3 OTC

Chapter 7 Market Estimates and Forecast, By Animal Type, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Dogs
7.3 Cats
7.4 Other animal types

Chapter 8 Market Estimates and Forecast, By Purchase Channel, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Veterinarian
8.3 Drug and pharmacy stores
8.4 Pet specialty stores
8.5 Supermarket / hypermarket
8.6 Online
8.7 Other purchase channels

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa